Role of double bronchial dilation in therapy of chronic obstructive lung disease
Abstract
Chronic obstructive lung disease (COLD) is a chronic progressive disease requiring timely treatment. Short-acting ß2-agonists and M-cholinergic drugs are emergency medicines. Long-acting ß2-agonists and M-cholinergic drugs are basic preparations and occupy central place in therapy of patients varying in symptoms severity. Their combinations considerably improve pulmonary function parameters, life quality and reliably decrease dyspnea, if compared to monotherapy. Combination of indakaterol/glycopirronium is widely proved scientifically to influence COLD exacerbations, if compared to monotherapy with long-acting ß2-agonists and M-cholinergic drugs and with combined inhaled corticosteroids with long-acting ß2-agonists. Corticosteroidal therapy has secondary importance in COLD therapy after optimal bronchial dilation. Corticosteroids should be prescribed strictly on indications in cases where they are really effective.
Keywords
хроническая обструктивная болезнь легких,
частые обострения,
комбинации ß2-агонистов и М-холинолитиков,
средства доставки,
отмена ИГКС,
chronic obstructive lung disease,
frequent exacerbations,
combination of ß2-agonists and M-cholinergic drugs,
delivery vehicles,
discontinuation of inhaled corticosteroids
About the Authors
I. I. Stepanova
Central state medical academy of department of presidential affairs of the Russia
Russian Federation
Russian Federation
S. A. Chorbinskaja
Central state medical academy of department of presidential affairs of the Russia
Russian Federation
Russian Federation
G. A. Baryshnikova
Central state medical academy of department of presidential affairs of the Russia
Russian Federation
Russian Federation
O. E. Blokhina
Central state medical academy of department of presidential affairs of the Russia
Russian Federation
Russian Federation
References
1. Авдеев С.Н. // Медицинский Совет. - 2016. - №15. - C. 14-20.
2. Всемирная организация здравоохранения, ХОБЛ, 2017
3. Зыков К.А, Овчаренко С.И. // Медицинский совет. - 2015. - №17. - С. 24-31.
4. Клинические рекомендации по ХОБЛ Российского респираторного общества МЗ РФ, 2016. - C. 1-68.
5. Beeh K.M., Korn S., Beir J. et al. // Respiratory Medicine, 2014. - 108. - P. 584-592.
6. Beeh K.M., Westerman J., Kirsten A.M. et al. // Pulmonary Pharmacology & Therapeutics. - 2015. - 32 - P. 53-59.
7. Cazzola M., Page C.P. ,Caizetta L. et al. // ASPET, pharmacological review. - 2012. - 64 (3) - P. 450-504.
8. Chenna P.R. and Mannino D.M. // SeminRespirCrit Care Med. - 2010. - 31(3). - P. - 286-294.
9. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease [GOLD] 2017, - P. 1-100.
10. Krüger P., Ehrlein B., Zier M., Greguletz R. // European Respiratory J. - 2014. - 44. - P. 4635.
11. Magnussen. H., Disse B., Rodriguez-Roisin R. et al.// N Engl J Med, 2014. - 371. - P. 1285-1294.
12. Maltais, F.,Singh S.,Donald A.C.et al. // Ther Adv Respir Dis 2014, - 8(6). - P. 169-181.
13. Miravitlles M., D'Urzo A., Singh D., Koblizek V. // Respiratory Research. - 2016. - 17. - P. 1-15.
14. Price D., West D., Brusselle G. et al. // Intern Journal of COPD, - 12. - 2017. - P. 141-168.
15. Price D., Mezzi K., Fedele M.J. et al. // Thorax. - 2013. - 68. - P. 387-396.
16. Rossi A., van der Molen T., Ricardo del Olmo et al. // Eur Respir J. - 2014. - 44 (6). - P. 1548-56.
17. Rossi A.,Guerriero M.,Corrado A. // Respiratory Research 2014. - 15 (77). - P. 1-12.
18. Suissa S., Dell'Aniello S., Ernst P. et al. // Thorax, 2012. - 67(11). - P. 957-963.
19. Wedzicha J.A, Banerji D, Chapman K.R., et al. // N Engl J Med. - 2016-374. - p. 2222-34
20. Wedzicha J.A. ,Decramer M.,Ficker J.A. et al. // The Lancet Respiratory Medicine. - 2013. - 1. - P. 199-209.
Review
For citations:
Stepanova I.I., Chorbinskaja S.A., Baryshnikova G.A., Blokhina O.E. Role of double bronchial dilation in therapy of chronic obstructive lung disease. Russian Journal of Occupational Health and Industrial Ecology. 2017;(8):7-10. (In Russ.)
Views:
739
Email this article 
